Vident Advisory’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Sell |
15,185
-791
| -5% | -$23.4K | 0.01% | 1122 |
|
|
2025
Q1 | $477K | Sell |
15,976
-922
| -5% | -$27.5K | 0.01% | 1059 |
|
|
2024
Q4 | $484K | Buy |
16,898
+3,672
| +28% | +$105K | 0.01% | 969 |
|
|
2024
Q3 | $511K | Sell |
13,226
-2,055
| -13% | -$79.4K | 0.01% | 908 |
|
|
2024
Q2 | $492K | Buy |
15,281
+7,671
| +101% | +$247K | 0.01% | 887 |
|
|
2024
Q1 | $295K | Sell |
7,610
-145
| -2% | -$5.63K | 0.01% | 1030 |
|
|
2023
Q4 | $239K | Buy |
+7,755
| New | +$239K | 0.01% | 1128 |
|